CRYOPORT INC (CYRX) Stock Price, Forecast & Analysis

NASDAQ:CYRX • US2290503075

8.42 USD
-0.11 (-1.29%)
At close: Feb 27, 2026
8.42 USD
0 (0%)
After Hours: 2/27/2026, 8:00:02 PM

CYRX Key Statistics, Chart & Performance

Key Statistics
Market Cap421.59M
Revenue(TTM)190.26M
Net Income(TTM)59.58M
Shares50.07M
Float48.07M
52 Week High11.45
52 Week Low4.58
Yearly DividendN/A
Dividend Yield0%
EPS(TTM)1.17
PE7.2
Fwd PEN/A
Earnings (Next)03-11
IPO2015-07-24
Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
CYRX short term performance overview.The bars show the price performance of CYRX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -5 -10

CYRX long term performance overview.The bars show the price performance of CYRX in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40 -40 -60

The current stock price of CYRX is 8.42 USD. In the past month the price decreased by -10.81%. In the past year, price increased by 51.17%.

CRYOPORT INC / CYRX Daily stock chart

CYRX Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to CYRX. When comparing the yearly performance of all stocks, CYRX is one of the better performing stocks in the market, outperforming 77.66% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
CYRX Full Technical Analysis Report

CYRX Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to CYRX. CYRX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
CYRX Full Fundamental Analysis Report

CYRX Financial Highlights

Over the last trailing twelve months CYRX reported a non-GAAP Earnings per Share(EPS) of 1.17. The EPS increased by 157.07% compared to the year before.


Industry RankSector Rank
PM (TTM) 31.31%
ROA 7.69%
ROE 11.61%
Debt/Equity 0.36
Chartmill High Growth Momentum
EPS Q2Q%-800%
Sales Q2Q%-21.94%
EPS 1Y (TTM)157.07%
Revenue 1Y (TTM)-15.86%
CYRX financials

CYRX Forecast & Estimates

15 analysts have analysed CYRX and the average price target is 13.49 USD. This implies a price increase of 60.17% is expected in the next year compared to the current price of 8.42.

For the next year, analysts expect an EPS growth of 222.58% and a revenue growth -23.65% for CYRX


Analysts
Analysts85.33
Price Target13.49 (60.21%)
EPS Next Y222.58%
Revenue Next Year-23.65%
CYRX Analyst EstimatesCYRX Analyst Ratings

CYRX Ownership

Ownership
Inst Owners103.06%
Ins Owners3.99%
Short Float %5.82%
Short Ratio7.02
CYRX Ownership

CYRX Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
SymbolCompany NameTechnical RatingFundamental RatingFPEMarket Cap
TMO THERMO FISHER SCIENTIFIC INC20.99195.414B
DHR DANAHER CORP24.8147.997B
BRKRP BRUKER CORP - BRKR 6 3/8 09/01/28142.7648.84B
A AGILENT TECHNOLOGIES INC18.234.215B
IQV IQVIA HOLDINGS INC13.6728.941B
MTD METTLER-TOLEDO INTERNATIONAL29.5627.999B
ILMN ILLUMINA INC25.9719.467B
WAT WATERS CORP22.0819.218B
WST WEST PHARMACEUTICAL SERVICES32.417.914B
MEDP MEDPACE HOLDINGS INC26.8712.594B

About CYRX

Company Profile

CYRX logo image CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 1,090 full-time employees. The company went IPO on 2015-07-24. The firm supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The firm's segments include Life Sciences Services and Life Sciences Products. The firm's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.

Company Info

CRYOPORT INC

112 Westwood Place, Suite 350

Brentwood TENNESSEE 37027 US

CEO: Jerrell W. Shelton

Employees: 1098

CYRX Company Website

CYRX Investor Relations

Phone: 19492321900

CRYOPORT INC / CYRX FAQ

What does CRYOPORT INC do?

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 1,090 full-time employees. The company went IPO on 2015-07-24. The firm supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The firm's segments include Life Sciences Services and Life Sciences Products. The firm's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.


Can you provide the latest stock price for CRYOPORT INC?

The current stock price of CYRX is 8.42 USD. The price decreased by -1.29% in the last trading session.


Does CYRX stock pay dividends?

CYRX does not pay a dividend.


What is the ChartMill technical and fundamental rating of CYRX stock?

CYRX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


How is the market expecting CYRX stock to perform?

15 analysts have analysed CYRX and the average price target is 13.49 USD. This implies a price increase of 60.17% is expected in the next year compared to the current price of 8.42.


Can you provide the PE ratio for CYRX stock?

The PE ratio for CRYOPORT INC (CYRX) is 7.2. This is based on the reported non-GAAP earnings per share of 1.17 and the current share price of 8.42 USD.


What is the market capitalization of CYRX stock?

CRYOPORT INC (CYRX) has a market capitalization of 421.59M USD. This makes CYRX a Small Cap stock.